Share:
Peer-Reviewed Publication
Health Aff (Millwood)2025;44(3):322-332.March 1, 2025Journal Article

Socioeconomically Disadvantaged Groups May Have Underused The Emergency Department For Nonavoidable Visits, 2018-22.

Richard K Leuchter1, Melody Craff2, Sitaram Vangala3, Chi-Hong Tseng4, Julia Cave Arbanas5, Cyrus Tabatabai-Yazdi6, Michael Hadfield7, Dale Skinner8, Cheryl L Damberg9, Catherine A Sarkisian10, John N Mafi11, Katherine L Kahn12
1Richard K. Leuchter (rleuchter@mednet.ucla.edu), University of California Los Angeles and Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California.
2Melody Craff, Milliman MedInsight, Seattle, Washington.
3Sitaram Vangala, University of California Los Angeles.
4Chi-Hong Tseng, University of California Los Angeles.
5Julia Cave Arbanas, University of California Los Angeles.
6Cyrus Tabatabai-Yazdi, University of California Los Angeles.
7Michael Hadfield, Milliman MedInsight.
8Dale Skinner, Milliman MedInsight.
9Cheryl L. Damberg, RAND Corporation, Santa Monica, California.
10Catherine A. Sarkisian, University of California Los Angeles and Veterans Affairs Greater Los Angeles Healthcare System.
11John N. Mafi, University of California Los Angeles and RAND Corporation.
12Katherine L. Kahn, University of California Los Angeles and RAND Corporation.

Abstract

In the decades preceding the COVID-19 pandemic, emergency department (ED) use increased more rapidly for socioeconomically disadvantaged patients than for advantaged patients, often because of barriers to accessing office-based care. However, it remains unknown whether the pandemic has had durable effects on socioeconomic disparities in ED use. We conducted a retrospective cohort study of ED visit…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.